News | May 04, 2024
Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr
The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024
The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024
The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
Syngene International has reported total income of Rs. 933 crores during the period ended March 31, 2024
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated
